STUDIES

IN EXTREMIS is composed of two complementary studies :

240 inclusions

 

MOSTE : MinOr Stroke Therapy Evaluation -

NIHSS 0-5​

LASTE: LArge Stroke Therapy Evaluation - ASPECT 0-5

203 inclusions

Estimated Enrollment :

824 patients

Interim analysis:

274 et 548 patients

Estimated Enrollment :

450patients